Vitality has implemented these guidelines for preliminary production of cannabosides, the firm’s cannabinoid prodrugs that are intended to target the gastrointestinal tract, hence avoid the harmful side effects of THC. The company has also recently finalized a services deal with a specialist analytical … Read More
The post Vitality Biopharma Inc (OTCMKTS:VBIO) Concludes Pivotal GMP Manufacturing Deals For … appeared first on Dagga Magazine.